item management s discussion and analysis of financial condition and results of operations the following discussion and analysis provides information which management believes is relevant to an assessment and understanding of the company s consolidated results of operations and financial condition 
the discussion should be read in conjunction with the consolidated financial statements and notes thereto 
results of operations the following table presents  as a percent of net sales  certain categories included in the company s consolidated statements of income for the periods indicated net sales operating expense cost of sales selling and administrative expense research and development expense income from operations interest income expense  net income before income taxes net income compared to sales for were  an increase of compared to sales of  in the increase is primarily a result of incremental sales volume associated with the ndm acquisition  which became effective february   and the birtcher and master medical acquisitions that were reflected in results only from march  and may   their respective dates of acquisition 
cost of sales increased to  in as compared to  in the company s gross margin percentage was in as compared to in the effects of the birtcher and master medical acquisitions had a significant positive impact on the overall corporate gross margin percentage which improved to an average of for the last three quarters of during  the ndm acquisition resulted in further manufacturing efficiencies 
however  partially offsetting these gains in gross margin percentage  were the effects of lower pricing on ecg electrodes and the effects of the ndm product line  which generally have lower gross margin percentages than the company s overall gross margin percentage 
selling and administrative expenses increased to  in as compared to  in as a percentage of sales  however  selling and administrative expense decreased from in to in due to economies of scale resulting from the completed acquisitions 
research and development expense was  in as compared to  in the company continues to conduct research activities in all of its product lines  with a particular emphasis on products for minimally invasive surgery 
net interest expense was  in as compared to  in in connection with the acquisitions of birtcher and master medical  the company borrowed approximately  bringing aggregate borrowing outstanding under its credit agreement to  while an additional  was borrowed in connection with the february acquisition of ndm  all indebtedness of the company under its credit agreement was repaid in march following the company s offering of  shares of common stock 
the company s effective tax rate for was as compared to in compared to the company had net sales of  for as compared to  in  an increase of  or 
the increase was substantially a result of the effects of the birtcher and master medical acquisitions 
the company s gross margin percentage was in as compared to in this increase was primarily a result of manufacturing efficiencies and economies of scale realized through the birtcher and master medical acquisitions 
on a quarterly basis  the gross margin percentage for the first quarter of was and approximated for each of the remaining three quarters of selling and administrative expense increased to  during compared to  in  an increase of  or  due primarily to the effects of the birtcher and master medical acquisitions 
however  as a percentage of net sales  selling and administrative expense declined to in as compared to in  due to the economies of scale resulting from the acquisitions of birtcher and medical 
research and development expense increased to  in as compared to  in research and development expenditures for reflect increased activities relative to integration and further development of birtcher products  as well as the continued emphasis on the development of surgical products for mis procedures 
the company incurred  in interest expense in compared to  in this increase reflects the incremental debt incurred as a result of the birtcher and master medical acquisitions 
the company s effective tax rate for was as compared to in liquidity and capital resources cash flows provided or used by operating  investing and financing activities for and are disclosed in the consolidated statements of cash flows 
net cash provided by operations was  for as compared to  provided by operations in operating cash flows for were aided by higher net income compared to the same period in depreciation and amortization in increased primarily due to the effects of the completed acquisitions 
operating cash flows for were negatively impacted by increases in accounts receivable and other current assets  and a reduction in accrued payroll and withholdings 
adding to cash flows from operations for this period was a reduction in deferred income taxes and the income tax benefit of stock option exercises 
net cash used by investing activities was  in compared to  in cash used for the acquisition of ndm was  additions to property  plant and equipment for amounted to  during  cash used for the master medical acquisition amounted to  and additions to property  plant and equipment amounted to cash flows from financing activities were  for in connection with the ndm acquisition on february   the company borrowed  bringing aggregate borrowings under its credit facility to  on march   the company completed an offering of common stock which raised  proceeds relating to the exercise of stock options and a warrant to purchase the company s common stock amounted to  and  respectively 
subsequent to the company s equity offering  all indebtedness under the company s credit agreement was repaid 
payments on long term debt and other obligations included  to liquidate ndm obligations assumed on connection with the acquisition 
the company s credit facility consists of a  secured revolving line of credit which expires in march this facility carries an interest rate of over libor depending on defined cash flow performance ratios 
nothing was outstanding under the credit agreement at december  management believes that cash generated from operations  its current cash resources and funds available under its credit agreement will provide sufficient liquidity to ensure continued working capital for operations and funding of capital expenditures in the foreseeable future 
inflation management does not believe that inflation has had or is likely to have any significant impact on the company s operations 

